Clinical Trial Update: The Qutenza Patch as Treatment for Disabling Treprostinil (Remodulin) Infusion Site Pain [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the Qutenza capsaicin patch to reduce pain at treprostinil (Remodulin) infusion sites in pulmonary hypertension and pulmonary …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension
• Pulmonary Hypertension

Drugs mentioned

• Qutenza Patch (capsaicin patch 8%)
• Remodulin (treprostinil)

Snippet

Sponsor: University of Rochester | Conditions: Pulmonary Hypertension, Pulmonary Arterial Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2016-02-22